Once-monthly continuous erythropoietin receptor activator (CERA) for haemoglobin maintenance in haemodialysis patients with chronic renal anaemia


Duman N., UYANIK A., Unsal A., Sezer S., ÇAMSARI T., Cirit M., ...More

CLINICAL KIDNEY JOURNAL, vol.7, no.5, 2014 (Peer-Reviewed Journal) identifier identifier

  • Publication Type: Article / Article
  • Volume: 7 Issue: 5
  • Publication Date: 2014
  • Doi Number: 10.1093/ckj/sfu079
  • Journal Name: CLINICAL KIDNEY JOURNAL
  • Journal Indexes: Emerging Sources Citation Index, Scopus

Abstract

Background. This study was conducted to evaluate the efficacy and safety of once-monthly continuous erythropoietin receptor activator (CERA) for maintenance of stable haemoglobin (Hb) levels in adult chronic renal anaemia patients on dialysis according to local clinical judgment in Turkey.